1026 / 1224
Drugs, SBRT and Oligometastases
•
Ongoing studies with VEGFI, TKI, Interleukin ...... are
evaluating
–
increase therapeutic efficacy
–
Pattern of failure
–
Fractionation schedules / target volumes
–
Treatment response
–
Side effects
•
No clear data
•
Good experience with conventional fractionation
in combination with Chemo or new biological
agences have to be analysed carefull with SBRT
•
Studies have to be performed